These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 660339)

  • 21. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of central diabetes insipidus in adults and children with desmopressin.
    Ziai F; Walter R; Rosenthal IM
    Arch Intern Med; 1978 Sep; 138(9):1382-5. PubMed ID: 686929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lengthening of the duration of action of DDAVP by "ineffective" doses of clofibrate in patients with pituitary diabetes insipidus.
    Radó JP; Marosi J
    Endokrinologie; 1976 Jun; 67(2):220-9. PubMed ID: 954691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug therapy of diabetes insipidus].
    Quist Paulsen A
    Tidsskr Nor Laegeforen; 1976 Aug; 96(23):1222-3. PubMed ID: 968848
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of central diabetes insipidus with a new synthetic preparation: DDAVP (1-deamino-8-D arginine vasopressin). Preliminary experience in 5 cases].
    Bernasconi S; Vanelli M; Giovannelli G
    Minerva Pediatr; 1975 Feb; 27(5):321-6. PubMed ID: 775282
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of adiuretin-SD (DDAVP) and pitressin tannate in diabetes insipidus].
    László C; János J; Ferenc L
    Orv Hetil; 1977 Jul; 118(28):1648-50. PubMed ID: 876650
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved psychological status of children under DDAVP therapy for central diabetes insipidus.
    Waggoner RW; Slonim AE; Armstrong SH
    Am J Psychiatry; 1978 Mar; 135(3):361-2. PubMed ID: 626231
    [No Abstract]   [Full Text] [Related]  

  • 31. [DDAVP in the treatment of acute neurosurgical diabetes insipidus].
    Zancaner F; Griner A; Galante E
    Minerva Med; 1984 Apr; 75(18):1063-7. PubMed ID: 6728257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of vasopressin analogues (DDAVP, DVDAVP) in the form of sublingual tablets in central diabetes insipidus.
    Laczi F; Mezei G; Julesz J; Lázló FA
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):63-8. PubMed ID: 7216552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of vasopressin analogue DDAVP in patients with postoperative diabetes insipidus (author's transl)].
    Kubota T; Kashiwara K; Ito H; Tani K; Yamamoto S
    No To Shinkei; 1981 Jun; 33(3):617-23. PubMed ID: 7259900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between the dose of 1-deamino-8-d-arginine vasopressin (ddavp) and the antidiuretic response in man.
    Radó JP; Marosi J; Fischer J; Takó J; Kiss N
    Endokrinologie; 1975 Nov; 66(2):184-95. PubMed ID: 1236681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial natriuretic peptide secretion was not directly affected by arginine vasopressin in diabetes insipidus.
    Shimizu H; Tanaka Y; Nakamura K; Uehara Y; Shimomura Y
    J Med; 1991; 22(4-5):299-305. PubMed ID: 1838565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antidiuretic action of 1-deamino-8-D-arginine vasopressin (DDAVP) in man.
    Radó JP; Marosi J; Szende L; Borbély L; Takó J; Fischer J
    Int J Clin Pharmacol Biopharm; 1976 Apr; 13(3):199-209. PubMed ID: 950263
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of diabetes insipidus with DDAVP, a synthetic analog of vasopressin].
    Kauli R; Laron Z
    Harefuah; 1975 Jul; 89(1):6-8. PubMed ID: 1158246
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment with DDAVP in central diabetes insipidus. Review of our experience].
    Bernasconi S; Vanelli M; Volta C; Solli R; Cavagni G; Giovannelli G
    Minerva Pediatr; 1978 Jul; 30(13):1111-4. PubMed ID: 672852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.